Intraperitoneal serous adenocarcinoma: A critical appraisal of three hypotheses on its cause

被引:83
作者
Piek, JMJ [1 ]
Kenemans, P [1 ]
Verheijen, RHM [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, NL-1007 MB Amsterdam, Netherlands
关键词
ovarian carcinoma; fallopian tube carcinoma; peritoneal carcinoma; ovarian surface epithelium; tubal epithelium; oviduct; mesothelium; Mullerian system;
D O I
10.1016/j.ajog.2004.02.067
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Serous ovarian, Fallopian tube, and peritoneal adenocarcinomas are remarkably similar, both in their morphology, as well as in their clinical behavior. Despite extensive clinical and fundamental research, controversy still exists on the origin of serous female adnexal tumors. Difficulties in identification of site of origin at late stage the of disease at detection, when ovary, Fallopian tube, and the abdominal cavity are usually all involved, in addition to their macroscopic and microscopic resemblance, are major causes of this debate. In 3 hypotheses, 3 possible tissues of origin are proposed: the ovarian surface epithelium, the Fallopian tube epithelium, and the secondary Mullerian system. Study design: We searched for all peer-reviewed articles and reviews that examined "serous ovarian carcinoma," "Fallopian tube carcinoma," "Mullerian system," "ovarian surface epithelium," "tubal epithelium," and "peritoneal." We included only articles that could give information on the origin of serous carcinomas. Additional articles were added by examining references of overview articles in relevant fields. Results: Discussed are the experimental data underlying these hypotheses. Conclusion: An attempt is made to integrate the 3 hypotheses into a comprehensive model of serous intraperitoneal adenocarcinogenesis. It can be concluded that the Fallopian tubes play a major role in the development of female serous cancer. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:718 / 732
页数:15
相关论文
共 292 条
[1]   ESTROGEN INDUCES EPIDERMAL GROWTH-FACTOR (EGF) RECEPTOR AND ITS LIGANDS IN HUMAN FALLOPIAN-TUBE - INVOLVEMENT OF EGF BUT NOT TRANSFORMING GROWTH-FACTOR-ALPHA IN ESTROGEN-INDUCED TUBAL CELL-GROWTH IN-VITRO [J].
ADACHI, K ;
KURACHI, H ;
HOMMA, H ;
ADACHI, H ;
IMAI, T ;
SAKATA, M ;
HIGASHIGUCHI, O ;
YAMAGUCHI, M ;
MORISHIGE, KI ;
SAKOYAMA, Y ;
MIYAKE, A .
ENDOCRINOLOGY, 1995, 136 (05) :2110-2119
[2]   PARITY, AGE AT FIRST CHILDBIRTH, AND RISK OF OVARIAN-CANCER [J].
ADAMI, HO ;
HSIEH, CC ;
LAMBE, M ;
TRICHOPOULOS, D ;
LEON, D ;
PERSSON, I ;
EKBOM, A ;
JANSON, PO .
LANCET, 1994, 344 (8932) :1250-1254
[3]  
ADAMS MR, 1977, J MED PRIMATOL, V6, P5
[4]   Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or-2 mutations - Implications for gross examination, cytology, and clinical follow-up [J].
Agoff, SN ;
Mendelin, JE ;
Grieco, VS ;
Garcia, RL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (02) :171-178
[5]  
Ahmad-Thabet S M, 2000, J Obstet Gynaecol Res, V26, P65
[6]  
Aoki Y, 2000, J REPROD MED, V45, P159
[7]   Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum [J].
Attanoos, RL ;
Webb, R ;
Dojcinov, SD ;
Gibbs, AR .
HISTOPATHOLOGY, 2002, 40 (03) :237-244
[8]   E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium [J].
Auersperg, N ;
Pan, J ;
Grove, BD ;
Peterson, T ;
Fisher, J ;
Maines-Bandiera, S ;
Somasiri, A ;
Roskelley, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6249-6254
[9]  
Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO
[10]  
2-G